Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders

6 Nov 2019

Abstract excerpt

Nonhematopoietic stem cells as a delivery platform of therapeutic useful genes have attracted widespread attention in recent years, owing to gained a long lifespan, easy separation, high proliferation, and high transfection capacity. Mesenchymal stem/stromal cells (MSCs) are the choice of the cells for gene and cell therapy due to high self-renewal capacity, high migration rate to the site of the tumor, and with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to RNA Interference and Gene Delivery
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31691976
DOI: 10.1002/jcp.29324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disordersPMID 31691976Read ↗

Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: Mirage or reality?Semantic proximity Read ↗

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesSemantic proximity Read ↗

An Update on the Therapeutic Potential of Stem Cells.Semantic proximity Read ↗

Mesenchymal stem cell-based gene therapy: A promising therapeutic strategySemantic proximity Read ↗

Stem-cell therapies for blood diseasesSemantic proximity Read ↗

Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic DiseasesSemantic proximity Read ↗

Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and ProspectsSemantic proximity Read ↗

Current state of gene therapy in sickle cell diseaseSemantic proximity Read ↗

Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative MedicineSemantic proximity Read ↗

Mesenchymal Stem Cells and Gene TherapySemantic proximity Read ↗

Recent Advances in Gene Therapy for Hemophilia: Projecting the PerspectivesSemantic proximity Read ↗

Genetic Engineering of Mesenchymal Stem Cells for Regenerative MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.